Author/Authors :
Li, Ang Department of Hepatobiliary Pancreatic Surgery - West China Hospital - Sichuan University, Sichuan Province, China , Prasoon, Pankaj Department of Hepatobiliary Pancreatic Surgery - West China Hospital - Sichuan University, Sichuan Province, China , Hong, Wu Department of Hepatobiliary Pancreatic Surgery - West China Hospital - Sichuan University, Sichuan Province, China , Lu, Hui Min Department of Hepatobiliary Pancreatic Surgery - West China Hospital - Sichuan University, Sichuan Province, China , Zhang, Zhao Da Department of Hepatobiliary Pancreatic Surgery - West China Hospital - Sichuan University, Sichuan Province, China , Zhaoda, Zhang Department of Hepatobiliary Pancreatic Surgery - West China Hospital - Sichuan University, Sichuan Province, China
Abstract :
The purpose of this analysis was to evaluate the technological viability, basic safety and consequence of central pancreatectomy (CP)
with pancreaticogastrostomy in properly chosen sufferers with noncancerous central pancreatic pathology. This research is centered on
the infirmary charts of West China hospital. We recruited 20 individuals from 2007 to 2009 diagnosed with benign cancerous growth of
pancreatic body and neck. They underwent pancreatic body and neck resection adhering to pancreaticogastrostomy. We carried out central
pancreatectomy following pancreaticogastrostomy in 20 patients: 8 with serous cyst adenomas, 11 with mucinous cystadenomas, and 1 with
neuroendocrine tumor. The position of all tumors was restricted to body and neck of the pancreas, measuring a mean ± standard deviation of
2.6±1.3cm. The mean post-operative hospital stay was 7 days (ranging from 6 to 16 days).There was no intraoperative additional complications.
From a technical perspective, CP is a safe and sound, pancreas-preserving pancreatectomy for non-enucleable non-cancerous pancreatic
pathology restricted to the pancreatic body.
